Influence of Citrobacter freundii on NINJ2 Expression and Oxaliplatin Resistance in Colorectal Cancer

Influence of Citrobacter freundii on NINJ2 Expression and Oxaliplatin Resistance in Colorectal Cancer

ABSTRACT Background Oxaliplatin, a third‐generation platinum‐based chemotherapeutic agent, is widely used in the treatment of colorectal cancer (CRC). However, some patients do not respond effectively to oxaliplatin, and intrinsic resistance to the drug poses a significant challenge. Recent studies...

Full description

Saved in:

Bibliographic Details
Main Authors:	Reio Ueta, Hiroo Imai, Ken Saijo, Yoshifumi Kawamura, Shuto Kodera, Chikashi Ishioka
Format:	Article
Language:	English
Published:	Wiley 2025-07-01
Series:	Cancer Medicine
Subjects:	bacterial culture filtrate Citrobacter freundii colon cancer gut microbiome oxaliplatin
Online Access:	https://doi.org/10.1002/cam4.70940
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of Vitamin C on Cadmium Depending Growth and Vitamin C Contents of Citrobacter Freundii
by: Fikret Karataş, et al.
Published: (2021-09-01)

Assessment of Combined Effects of Selenium and Cadmium on Antioxidant Activity of Enzymes Produced by Citrobacter freundii
by: Salihu, M. I., et al.
Published: (2024-06-01)

Citrobacter freundii Brain Abscess in a Preterm Infant: A Case Report and Literature Review
by: Nishad Plakkal, et al.
Published: (2013-04-01)

From presentation to prognosis: a challenging case of multifocal cerebral microabscesses due to Citrobacter freundii
by: Varsha Nandwana, et al.
Published: (2025-05-01)

A novel bacterial approach to cassava waste fermentation: Reducing cyanide toxicity and improving quality to ensure livestock feed safety
by: Hera Dwi Triani, et al.
Published: (2025-03-01)

Brain abscess by citrobacter diversus in infancy: case report
by: RUBENS FEFERBAUM, et al.
Published: (2000-09-01)

Cathelicidin regulates goblet cell mucus secretion and mucus-associated proteins in Citrobacter rodentium-induced colitis
by: Niloofar Mirzadzare, et al.
Published: (2025-12-01)

Epidemiology, phylogeny and genetic characterization of carbapenem-resistant Citrobacter spp. from 5 hospitals in China
by: Qiang Zhao, et al.
Published: (2025-05-01)

Can Cobalamin prevent Oxaliplatin induced peripheral neuropathy?
by: Naza Shakir Shareef Shekhany, et al.
Published: (2023-06-01)

Exploring the bioremediation potential of Citrobacter spp. and Klebsiella spp. newly isolated from the industrial effluents of Eastern Shewa, Ethiopia
by: Duguma Dibbisa Itana, et al.
Published: (2025-01-01)

Bioremediation Activity of Pb (II) Resistance Citrobacter sp. MKH2 Isolated from Heavy Metal Contaminated Sites in Iran
by: M. Mohseni
Published: (2014-06-01)

Dataset for the near-complete hybrid genome assembly of Citrobacter werkmanii UPMLSS01 isolated from Borneo river and insights into its native antibiotic resistance repertoireNCBI
by: Sui Sien Leong, et al.
Published: (2025-08-01)

Oxaliplatin-induced lung fibrosis
by: Shah Arpan, et al.
Published: (2009-01-01)

Emerging trends of nosocomial Citrobacter species surgical wound infection: concern for infection control
by: B Thapa, et al.
Published: (2012-01-01)

Emerging trends of nosocomial Citrobacter species surgical wound infection: concern for infection control
by: B Thapa, et al.
Published: (2012-01-01)

Citrobacter youngae nosocomial bacteremia from postoperative pyogenic spondylodiscitis after a minimally invasive spinal surgery
by: Nguyen Sy Thau, et al.
Published: (2024-12-01)

Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay
by: Meher Rizvi, et al.
Published: (2009-05-01)

Isolation and algicidal characteristics of Citrobacter sp. strain N10
by: SUN Pengfei, et al.
Published: (2013-11-01)

The effect of Euonymus Fortunei extract combined with oxaliplatin on the IKKβ/NF-κB signaling pathway in colon cancer
by: Liu Jiaxuan, et al.
Published: (2024-10-01)

Characterization of Citrobacter sp. line 328 as a source of Vi for a Vi-CRM197 glycoconjugate vaccine against Salmonella Typhi
by: Simona Rondini, et al.
Published: (2012-11-01)

In silico discovery of druggable targets in Citrobacter koseri using echinoderm metabolites and molecular dynamics simulation
by: Bayan A. Alhaidhal, et al.
Published: (2024-11-01)

Stability study of oxaliplatin and doxorubicin for intraperitoneal administration with hyperthermia
by: V. Escudero-Ortiz, et al.
Published: (2014-05-01)

Activity of LpxC inhibitors on carbapenemase-producing Citrobacter spp. clinical isolates
by: Víctor Vinuesa, et al.
Published: (2025-09-01)

Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules
by: Bhawna Sirohi, et al.
Published: (2016-01-01)

Some aspects of liposomal oxaliplatin formulations
by: A. V. Stadnichenko, et al.
Published: (2015-02-01)

Intra-arterial hepatic chemotherapy in metastatic colorectal cancer: differences between oxaliplatin-naive versus oxaliplatin-pretreated patients
by: E. El Rawadi, et al.
Published: (2025-06-01)

Comparison of PSOX (paclitaxel, oxaliplatin, S-1) and SOX (oxaliplatin, S-1) as postoperative adjuvant chemotherapy for stage II-III gastric cancer
by: Fei-Yu Wang, et al.
Published: (2025-03-01)

Therapeutic effect of Chelidonium majus hydro-alcoholic extract alone and in combination with oxaliplatin on ovarian cancer cell line
by: Zahra Hashempour, et al.
Published: (2025-07-01)

Lactobacillus plantarum-derived extracellular vesicles from dietary barley leaf supplementation attenuate Citrobacter rodentium infection and intestinal inflammation
by: Yu Feng, et al.
Published: (2025-06-01)

Multi-Pathway Study for Oxaliplatin Resistance Reduction
by: Tong Ye, et al.
Published: (2025-03-01)

Oxaliplatin combined with capecitabine therapy and comprehensive nursing in advanced colorectal cancer patients
by: Dan Kuang, et al.
Published: (2025-07-01)

Salinomycin and oxaliplatin synergistically enhances cytotoxic effect on human colorectal cancer cells in vitro and in vivo
by: Fang Liu, et al.
Published: (2025-04-01)

Prophylactic administration of lecithinized superoxide dismutase for a murine model of oxaliplatin-induced myelosuppression
by: Mikako Shimoda, et al.
Published: (2025-07-01)

Oxaliplatin-induced neuropathic pain in cancer: animal models and related research progress
by: Yuxin Jiang, et al.
Published: (2025-05-01)

A rare case of localized peliosis hepatis during adjuvant chemotherapy including oxaliplatin mimicking a liver metastasis of colon cancer
by: Akira Dejima, et al.
Published: (2023-11-01)

Modification of gemcitabine with oxaliplatin in China for unresectable gallbladder cancer: a cost-effectiveness analysis
by: Zhaoyan Chen, et al.
Published: (2024-12-01)

Hepatoprotective and anti-inflammatory effects of entecavir or probiotics on Oxaliplatin-Induced Liver Injury in the rats.
by: Asem A. Askandar, et al.
Published: (2023-09-01)

Photodynamic therapy augments oxaliplatin-induced immunogenic cell death in colorectal cancer
by: Xiaobo Wang, et al.
Published: (2023-09-01)

Independent risk and protective factors for oxaliplatin-induced hypersensitivity reactions: a retrospective study
by: Jing Xue, et al.
Published: (2025-07-01)

Biosynthesis of Iron Oxide Nanoparticles Using Food Origin Citrobacter freundii in Optimized Conditions
by: Marwa H. AlKhafaji, et al.
Published: (2024-12-01)